Radiotherapy Market by Product (Devices [LINAC, Gamma Knife, Cyber Knife, Cyclotron, Synchrotron, Brachytherapy], Services, Software) Technology (IMRT, IGRT, 3D-CRT, Proton Beam Therapy, PDR-BT) Cancer (Breast, Prostate, Lung) - Global Forecast to 2030
세계 방사선 치료 시장은 2023-2030년간 연평균 8.4%의 성장률로 성장하여 2030년까지 178억 6,000만 달러에 달할 것으로 예상됩니다.
이 보고서는 광범위한 2차 및 1차 연구와 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 도전 과제 및 기회 분석으로 구성됩니다. 시장 성장 촉진요인은 암 발병률 증가, 방사선 치료의 기술적 진보, 암 치료에서 방사선 치료의 이점에 대한 인식 증가, 의료비 지출 증가, 암 치료에서 입자선 치료의 사용 증가 등입니다. 시장 성장을 저해하는 요인으로는 방사선 치료 기술의 높은 비용과 복잡성, 불충분한 첨단 인프라, 숙련된 의료 전문가 부족 등이 있습니다.
또한, 신흥국의 높은 성장 기회와 공공 및 민간 기관의 암 연구에 대한 투자 증가는 큰 시장 성장 기회를 제공할 것으로 예상됩니다. 그러나 방사선 치료 중 종양의 가시화 어려움과 방사선 노출에 따른 위험은 시장 성장에 큰 걸림돌로 작용하고 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 시장 인사이트
- 개요
- 성장 촉진요인
- 성장 억제요인
- 기회
- 과제
- 가격 분석
제5장 세계의 방사선 치료 시장 규모와 동향 분석 : 제품별
- 개요
- 방사선 치료 기기
- 외부 빔 방사선 치료
- 기존 선형 가속기
- 기존 Co-60 원격 치료 장비
- 첨단 정위 방사선 치료 장비
- 양자선 치료 시스템/입자선 치료 시스템
- 내부 빔 방사선 치료 시스템/근접치료 시스템
- 방사선 치료 소모품 및 부속품
- 서비스
- 소프트웨어
제6장 세계의 방사선 치료 시장 규모와 동향 분석 : 기술별
- 개요
- 외부 빔 방사선 치료
- 강도 조절 방사선 치료(IMRT)
- 영상 유도 방사선 치료(IGRT)
- 정위 방사선 치료(SRT)
- 3D-CRT
- 양자선 치료/입자선 치료
- 내부 빔 방사선 치료
- 근접치료
- 고선량율 근접치료
- 저선량율 근접치료
- 이미지 가디으 근접치료
- 펄스 선량율 근접치료
- 전신 방사선 요법
제7장 세계의 방사선 치료 시장 규모와 동향 분석 : 암별
- 개요
- 유방암
- 전립선암
- 폐암
- 두경부암
- 대장암
- 자궁경부암
- 기타 암
제8장 방사선 치료 시장 규모·동향 분석 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제9장 경쟁 분석
- 개요
- 주요 성장 전략
- 벤더의 시장 포지셔닝
- 경쟁 대시보드
- 업계 리더
- 시장 차별화 요인
- 선행 기업
- 신규 기업
- 시장 점유율 분석(2022년)
제10장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개)
- Siemens Healthineers AG
- Elekta AB
- Accuray Incorporated
- IBA
- Mevion Medical Systems, Inc.
- Hitachi, Ltd.
- ViewRay Technologies, Inc.
- Panacea Medical Technologies Pvt. Ltd.
- IsoRay, Inc.
- Optivus Proton Therapy, Inc
- P-Cure, Ltd.
제11장 부록
LSH
Radiotherapy Market Size, Share, Forecast, & Trends Analysis by Product (Devices [LINAC, Gamma Knife, Cyber Knife, Synchrotron, Brachytherapy], Services, Software) Technology (IMRT, 3D-CRT, PDR-BT) Cancer (Breast, Prostate, Lung)-Global Forecast to 2030
The global radiotherapy market is projected to reach $17.86 billion by 2030 at a CAGR of 8.4% from 2023 to 2030.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The market drivers are the increasing cancer incidence rate, technological advancements radiotherapy, growing awareness about the benefits of radiotherapy for cancer treatment, growing healthcare expenditure, and growing use of particle therapy for cancer treatment. The market growth is hindered by the high costs and complexities of radiotherapy procedures, inadequate advanced infrastructure, and a shortage of skilled healthcare professionals.
Furthermore, the high growth prospects in emerging economies and rising investments by public & private organizations in cancer research are expected to offer significant market growth opportunities. However, the difficulties in visualizing tumors during radiotherapy procedures and the risks associated with radiation exposure are the major challenges to the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global radiotherapy market are Siemens Healthineers AG (Germany), Elekta AB (Sweden), Accuray Incorporated (U.S.), IBA (Belgium), Mevion Medical Systems, Inc. (U.S.), Hitachi, Ltd. (Japan), ViewRay Technologies, Inc. (U.S.), Panacea Medical Technologies Pvt. Ltd. (India), IsoRay, Inc. (U.S.), Optivus Proton Therapy, Inc. (U.S.), and P-Cure Ltd. (Israel).
Among all the products studied in this report, in 2023, the radiotherapy devices segment is expected to account for the largest share of the radiotherapy market. The two types of radiotherapy devices are external and internal beam radiotherapy devices. CyberKnife is a form of non-invasive therapy that uses high doses of specifically designed radiation to eliminate cancers in the body. The adoption of CyberKnife is significantly higher than other external beam devices. The large market share of this segment is attributed to the benefits of CyberKnife, for its painless, non-invasive nature with few to no side effects.
Among all the technologies studied in this report, in 2023, the external beam radiotherapy segment is expected to account for the largest share of the radiotherapy market. The large market share of this segment is attributed to the high precision of external beam therapy. The developments in external beam therapy allow for higher and more precise radiation doses and reduce damage to healthy tissues. Moreover, the preference for external radiotherapy is higher among patients unsuitable for surgery.
Among all the cancer types studied in this report, in 2023, the prostate cancer segment is expected to account for the largest share of the radiotherapy market. The largest share of this segment is attributed to the high incidence of prostate cancer, and higher success rate of radiotherapy in prostate cancer than other cancers. For instance, according to Radiation Oncology Targeting Cancer data, external-beam radiation therapy cures 95.5% of men with localized prostate cancer.
An in-depth analysis of the geographical scenario of the global radiotherapy market provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the radiotherapy market. In 2023, the U.S. is expected to account for the largest share of the radiotherapy market in North America. The large share of this regional market is attributed to the high healthcare expenditure for cancer, highly developed healthcare infrastructure, the presence of key cancer radiotherapy developing companies such as Accuray Incorporated (U.S.) and Mevion Medical Systems, Inc. (U.S.), and government programs supporting early cancer screening.
Scope of the Report:
Radiotherapy Market Assessment-by Product
- Radiotherapy Devices
- External-beam Radiotherapy
- Conventional Linear Accelerators
- Conventional Co-60 Teletherapy Units
- Advanced Stereotactic Radiotherapy Systems
- Gamma Knife
- CyberKnife
- TomoTherapy
- Proton Beam Therapy Systems/Particle Beam Therapy Systems
- Cyclotron
- Synchrotron
- Synchrocyclotron
- Internal Beam Radiotherapy Systems/Brachytherapy Systems Seeds
- Electronic Brachytherapy Products Applicators
- Afterloaders
- Radiotherapy Consumables and Accessories
- Services
- Software
Radiotherapy Market Assessment-by Technology
- External Beam Radiotherapy
- Intensity Modulated Radiation Therapy (IMRT)
- Image Guided Radiation Therapy (IGRT)
- Stereotactic Radiation Therapy (SRT)
- 3D Conformal Radiation Therapy (3D-CRT)
- Proton Beam Therapy/Particle Beam Therapy
- Internal Beam Radiotherapy
- High dose-rate Brachytherapy
- Low dose-rate Brachytherapy
- Image Guided Brachytherapy
- Pulse dose-rate Brachytherapy
- Systemic Radiation Therapy
- Intravenous Radiotherapy
- Oral Radiotherapy
Radiotherapy Market Assessment-by Cancer Type
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Cervical Cancer
- Other Cancers
Note: Other cancers include kidney cancer, ovarian cancer, pancreatic cancer, and stomach cancer.
Radiotherapy Market Assessment-by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
TABLE OF CONTENTS
1. Overview
- 1.1. Market Definition & Scope
- 1.2. Market Ecosystem
- 1.3. Currency
- 1.4. Key Stakeholders
2. Research Methodology
- 2.1. Research Approach
- 2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
- 2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
- 4.1. Overview
- 4.2. Drivers
- 4.2.1. Rising Cancer Incidence
- 4.2.2. Technological Advancements in the Field of Radiotherapy
- 4.2.3. Growing Awareness About the Benefits of Radiotherapy for Cancer Treatment
- 4.2.4. Growing Healthcare Expenditure
- 4.2.5. Rising Use of Particle Therapy for Cancer Treatment
- 4.3. Restraints
- 4.3.1. High Cost and Complexities Associated with Radiotherapy Procedures
- 4.3.2. Lack of Advanced Infrastructure Facilities
- 4.3.3. Lack of Skilled Healthcare Professionals
- 4.4. Opportunities
- 4.4.1. High Growth Prospects in Emerging Economies
- 4.4.2. Rising Investments by Public and Private Organizations for Cancer Research
- 4.5. Challenges
- 4.5.1. Difficulties in Visualizing Tumors during Radiotherapy Procedures
- 4.5.2. Risks Associated with Radiation Exposures
- 4.6. Pricing Analysis
5. Global Radiotherapy Market Size & Trend Analysis, by Product
- 5.1. Overview
- 5.2. Radiotherapy Devices
- 5.2.1. External Beam Radiotherapy
- 5.2.1.1. Conventional Linear Accelerators
- 5.2.1.2. Conventional Co-60 Teletherapy Units
- 5.2.1.3. Advanced Stereotactic Radiotherapy Systems
- 5.2.1.3.1. Gamma Knife
- 5.2.1.3.2. CyberKnife
- 5.2.1.3.3. TomoTherapy
- 5.2.1.4 Proton Beam Therapy Systems/Particle Beam Therapy Systems
- 5.2.1.4.1. Cyclotron
- 5.2.1.4.2. Synchrotron
- 5.2.1.4.3. Synchrocyclotron
- 5.2.2. Internal Beam Radiotherapy Systems/Brachytherapy Systems
- 5.2.2.1. Electronic Brachytherapy Products
- 5.2.2.2. Afterloaders
- 5.3. Radiotherapy Consumables and Accessories
- 5.4. Services
- 5.5. Software
6. Global Radiotherapy Market Size & Trend Analysis, by Technology
- 6.1. Overview
- 6.2. External Beam Radiotherapy
- 6.2.1. Intensity-Modulated Radiation Therapy (IMRT)
- 6.2.2. Image-Guided Radiation Therapy (IGRT)
- 6.2.3. Stereotactic Radiation Therapy (SRT)
- 6.2.4. 3D Conformal Radiation Therapy (3D-CRT)
- 6.2.5. Proton Beam Therapy/ Particle Beam Therapy
- 6.3. Internal Beam Radiotherapy
- 6.3.1. Brachytherapy
- 6.3.1.1. High Dose Rate Brachytherapy
- 6.3.1.2. Low Dose Rate Brachytherapy
- 6.3.1.3. Image Guided Brachytherapy
- 6.3.1.4. Pulse Dose Rate Brachytherapy
- 6.3.2. Systemic Radiation Therapy
- 6.3.2.1. Intravenous Radiotherapy
- 6.3.2.2 Oral Radiotherapy
7. Global Radiotherapy Market Size & Trend Analysis, by Cancer Type
- 7.1. Overview
- 7.2. Breast Cancer
- 7.3. Prostate Cancer
- 7.4. Lung Cancer
- 7.5. Head and Neck Cancer
- 7.6. Colorectal Cancer
- 7.7. Cervical Cancer
- 7.8. Other Cancers
8. Radiotherapy Market Size & Trend Analysis, by Geography
- 8.1. Overview
- 8.2. North America
- 8.2.1. U. S.
- 8.2.2. Canada
- 8.3. Europe
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
- 8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia-Pacific
- 8.5. Latin America
- 8.5.1. Brazil
- 8.5.2. Mexico
- 8.5.3. Rest of Latin America
- 8.6. Middle East & Africa
9. Competition Analysis
- 9.1. Overview
- 9.2. Key Growth Strategies
- 9.3. Vendor Market Positioning
- 9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
- 9.5. Market Share Analysis (2022)
10. Company Overview (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
- 10.1. Siemens Healthineers AG
- 10.2. Elekta AB
- 10.3. Accuray Incorporated
- 10.4. IBA
- 10.5. Mevion Medical Systems, Inc.
- 10.6. Hitachi, Ltd.
- 10.7. ViewRay Technologies, Inc.
- 10.8. Panacea Medical Technologies Pvt. Ltd.
- 10.9. IsoRay, Inc.
- 10.10. Optivus Proton Therapy, Inc
- 10.11. P-Cure, Ltd.
11. Appendix
- 11.1. Available Customization
- 11.2. Related Reports
